Abstract
Breast cancer is the most common cancer suffered by female, and the second highest cause of cancer-related death among women worldwide. At present, hormone therapy is still the main treatment route and can be divided into three main categories: selective estrogen receptor modulators (SERMs), selective estrogen receptor downregulators (SERDs), and aromatase inhibitors (AIs). However, breast cancer is difficult to cure even after several rounds of anti-estrogen therapy and most drugs have serious side-effects. Here, we review the literature published over the past five years regarding the isolation and synthesis of analogs and their derivatives.
Keywords:
Analogs; Bioactivity; Breast cancer; Derivatives; Estrogen receptor α; Structure-activity relationship..
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
MeSH terms
-
Animals
-
Antineoplastic Agents / chemistry
-
Antineoplastic Agents / isolation & purification
-
Antineoplastic Agents / pharmacology*
-
Aromatase Inhibitors / chemistry
-
Aromatase Inhibitors / isolation & purification
-
Aromatase Inhibitors / pharmacology*
-
Breast Neoplasms / drug therapy*
-
Breast Neoplasms / metabolism
-
Breast Neoplasms / pathology
-
Cell Proliferation / drug effects
-
Drug Screening Assays, Antitumor
-
Estrogen Receptor Antagonists / chemistry
-
Estrogen Receptor Antagonists / isolation & purification
-
Estrogen Receptor Antagonists / pharmacology*
-
Estrogen Receptor Modulators / chemistry
-
Estrogen Receptor Modulators / isolation & purification
-
Estrogen Receptor Modulators / pharmacology*
-
Estrogen Receptor alpha / antagonists & inhibitors*
-
Estrogen Receptor alpha / metabolism
-
Female
-
Humans
-
Molecular Structure
Substances
-
Antineoplastic Agents
-
Aromatase Inhibitors
-
Estrogen Receptor Antagonists
-
Estrogen Receptor Modulators
-
Estrogen Receptor alpha